Elsevier

Pancreatology

Volume 11, Issue 2, August 2011, Pages 252-260
Pancreatology

The Role of Phosphatidylinositol 3-Kinase Signaling Pathways in Pancreatic Cancer

https://doi.org/10.1159/000327715Get rights and content

Abstract

Background: Pancreatic cancer is a highly malignant cancer and the fourth leading cause of cancer-related death. It is characterized by a rapid disease progression, a highly invasive tumor phenotype, and frequently resistance to chemotherapy. Despite significant advances in diagnosis, staging, and surgical management of the disease during the past decade, prognosis of pancreatic cancer is still dismal. Methods and Results: The phosphatidylinositol 3-kinase (PI3K) signaling pathways regulate cellular growth, metabolism, survival, and motility in pancreatic cancer. Pancreatic cancer is associated with a high degree of genetic alterations that can result in aberrant activation of the PI3K signaling pathway. Elucidating the role of the PI3K signaling pathway in pancreatic cancer may thus be both meaningful and necessary. Conclusion: Improved knowledge of the PI3K signaling pathway in pancreatic cancer would furthermore be helpful in understanding mechanisms of tumor initiation and progression, and in identifying appropriate targeted anticancer treatment in pancreatic cancer.

References (96)

  • M Zhang et al.

    Stem cell factor/c-kit signaling enhances invasion of pancreatic cancer cells via HIF-lα under normoxic condition

    Cancer Lett

    (2011)
  • M Edderkaoui et al.

    NADPH oxidase activation in pancreatic cancer cells is mediated through Akt-dependent up-regulation of p22phox

    J Biol Chem

    (2011)
  • P Gerwins et al.

    Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis

    Crit Rev Oncol Hematol

    (2000)
  • RA Perugini et al.

    Pancreatic cancer cell proliferation is phosphatidylinositol 3-kinase dependent

    J Surg Res

    (2000)
  • SR Datta et al.

    Akt phosphorylation of bad couples survival signals to the cell-intrinsic death machinery

    Cell

    (1997)
  • BN Fahy et al.

    Inhibition of Akt abrogates chemotherapy-induced NFκB survival mechanisms: implications for therapy in pancreatic cancer

    J Am Coll Surg

    (2004)
  • MG Binker et al.

    EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2

    Biochem Biophys Res Commun

    (2009)
  • MG Binker et al.

    Hypoxia-reoxygenation increase invasiveness of PANC-1 cells through Rac1/MMP-2

    Biochem Biophys Res Commun

    (2010)
  • J Ma et al.

    IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/ PI3K/Akt signaling pathway in pancreatic cancer cells

    J Surg Res

    (2010)
  • ZA Knight et al.

    A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling

    Cell

    (2006)
  • MJ Berna et al.

    Gastrointestinal growth factors and hormones have divergent effects on Akt activation

    Cell Signal

    (2009)
  • J Yao et al.

    Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway

    Med Oncol

    (2010)
  • S Westphal et al.

    Apoptosis: targets in pancreatic cancer

    Mol Cancer

    (2003)
  • DM Parkin et al.

    Cancer burden in the year 2000. The global picture

    Eur J Cancer

    (2001)
  • A Jemal et al.

    Cancer statistics, 2010

    CA Cancer J Clin

    (2010)
  • RA Fryer et al.

    Recent advances and developments in treatment strategies against pancreatic cancer

    Curr Clin Pharmacol

    (2009)
  • N Jonckheere et al.

    Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by ap-2α overex-pression

    Br J Cancer

    (2009)
  • S Jones et al.

    Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

    Science

    (2008)
  • F Schonleben et al.

    Pik3ca mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas

    Clin Cancer Res

    (2006)
  • Y Jiao et al.

    DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

    Science

    (2011)
  • L Zhao et al.

    Class I PI3K in oncogenic cellular transformation

    Oncogene

    (2008)
  • A Kierbel et al.

    The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for pseudomonas aeruginosa strain PAK internalization

    Mol Biol Cell

    (2005)
  • B Vanhaesebroeck et al.

    The PI3K-PDK1 connection: more than just a road to PKB

    Biochem J

    (2000)
  • LC Cantley

    The phosphoinositide 3-kinase pathway

    Science

    (2002)
  • R Aikin et al.

    Crosstalk between phosphatidylinositol 3-kinase/ Akt and c-Jun NH2-terminal kinase mediates survival of isolated human islets

    Endocrinology

    (2004)
  • M Reichert et al.

    Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells

    Cancer Res

    (2007)
  • C Schild et al.

    PI3K signaling maintains c-Myc expression to regulate transcription of E2F1 in pancreatic cancer cells

    Mol Carcinog

    (2009)
  • J Shaw et al.

    Antagonism of E2F-1 regulated BNIP3 transcription by NF-κB is essential for basal cell survival

    Proc Natl Acad Sci USA

    (2008)
  • JA Diehl et al.

    Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization

    Genes Dev

    (1998)
  • P Cohen et al.

    The renaissance of GSK3

    Nat Rev Mol Cell Biol

    (2001)
  • AG Bader et al.

    Oncogenic PI3K deregulates transcription and translation

    Nat Rev Cancer

    (2005)
  • LS Steelman et al.

    Akt as a therapeutic target in cancer

    Expert Opin Ther Targets

    (2008)
  • SJ Zacharek et al.

    Negative regulation of TSC1-TSC2 by mammalian D-type cyclins

    Cancer Res

    (2005)
  • H Zhang et al.

    Loss of TSC1/ TSC2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR

    J Clin Invest

    (2003)
  • H Zhang et al.

    PDGFRs are critical for PI3K/ Akt activation and negatively regulated by mTOR

    J Clin Invest

    (2007)
  • LS Harrington et al.

    The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins

    J Cell Biol

    (2004)
  • L Ma et al.

    Genetic analysis of PTEN and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression

    Genes Dev

    (2005)
  • E Missiaglia et al.

    Pancreatic endocrine tumors: expression profiling evidences a role for Akt-mTOR pathway

    J Clin Oncol

    (2010)
  • Cited by (0)

    1

    Prof. Roland Andersson Department of Surgery, Clinical Sciences Lund Skåne University Hospital Lund SE-221 85 Lund (Sweden) Tel. +46 46 17 23 59

    View full text